APA

Sinclair P. B., Ryan S., Bashton M., Hollern S., Hanna R., Case M., Schwalbe E. C., Schwab C. J., Cranston R. E., Young B. D., Irving J. A. E., Vora A. J., Moorman A. V. & Harrison C. J. (20191028). SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain. : Leukemia.

Chicago

Sinclair Paul B, Ryan Sarra, Bashton Matthew, Hollern Shaun, Hanna Rebecca, Case Marian, Schwalbe Edward C, Schwab Claire J, Cranston Ruth E, Young Brian D, Irving Julie A E, Vora Ajay J, Moorman Anthony V and Harrison Christine J. 20191028. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain. : Leukemia.

Harvard

Sinclair P. B., Ryan S., Bashton M., Hollern S., Hanna R., Case M., Schwalbe E. C., Schwab C. J., Cranston R. E., Young B. D., Irving J. A. E., Vora A. J., Moorman A. V. and Harrison C. J. (20191028). SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain. : Leukemia.

MLA

Sinclair Paul B, Ryan Sarra, Bashton Matthew, Hollern Shaun, Hanna Rebecca, Case Marian, Schwalbe Edward C, Schwab Claire J, Cranston Ruth E, Young Brian D, Irving Julie A E, Vora Ajay J, Moorman Anthony V and Harrison Christine J. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain. : Leukemia. 20191028.